EQL Pharma – en originell generikaaktör. Av: Daniel Svensson, Peter Nilsson. EQL utvecklar och marknadsför nischgenerika. Bolaget ligger långt efter den ursprungliga planen som presenterades i samband med noteringen 2013. Men portföljen består av 8 produkter idag som sålde för strax under 30 Mkr 2016 så det rör sig framåt.

Med hänvisning till att EQL Pharma AB inte längre är föremål för ett offentligt uppköpserbjudande har Spotlight Stock Market beslutat att bolagets aktie ska.

The reason for the limited competition is that these drugs often have a small turnover globally, but a relatively larger turnover in a specific geography, such as a country or a region of countries. One (1) subscription option TO 2 gives the right to subscribe for one (1) new share in EQL Pharma. The subscription price shall be 70 percent of the volume-weighted trading price of SPOTLIGHT during the period of 10 trading days ending five banking days before the first subscription date, but not less than SEK 3.50 and a maximum of SEK 5.50. EQL Pharma AB's Gross Margin % for the three months ended in Dec. 2020 was 35.48%. EQL Pharma AB COGS-to-Revenue Historical Data * All numbers are in millions except for per share data and ratio. The graphic below shows how CEO compensation at EQL Pharma has changed from year to year.

Utvikling i dag. −1,80%. −0,6. Kjøp. 32,8. Selg. 33,8.

16 hours ago EQL Pharma revises the schedule for the planned list change from Spotlight Stock Market to Nasdaq.

2016-09-12 In the disclosure notice published by Fårö Capital on March 19th, 2019, it is stated that Fårö Capital on March 19th, 2019 has acquired 332,000 shares in EQL Pharma, corresponding to approximately 1.1 percent of the votes and capital of EQL Pharma and that the acquisition was carried out in a block post outside the market through a cash acquisition at a price of SEK 11.35 per share in EQL Pharma. EQL Pharma AB has today, entered into a strategic agreement with Cadila Pharmaceuticals Limited (Cadila Pharma).

Find the latest ALPS Equal Sector Weight ETF (EQL) stock quote, history, news and other vital information to help you with your stock trading and investing.

EQL Pharmas läkemedel Pregabalin EQL Pharma har godkänts för försäljning av Läkemedelsverket. Publicerad: 19 december 2018, 16:30. Visa fler. Company profile page for EQL Pharma AB including stock price, company news, press releases, executives, board members, and contact information 2019-12-20 EQL Pharma's share has been listed on Spotlight Stock Market since 2013 and in Spotlight's new segment Next since October 31, 2019. Companies traded in this segment follow stricter rules regarding, among other things, accounting principles than other companies listed on Spotlight Stock Market. The disadvantage of the Retail segment is, of course, that easily won is just as easily lost if a competitor can offer a lower price. This makes inventory planning and market knowledge central assets within EQL in order to be able to balance correctly between opportunities and risks when prices change on an annual, quarterly, monthly or weekly basis.

EQL Pharma AB (publ)University of Gothenburg Support for pricing and parallell trade business areas 5. 02:27 - EQL Pharma05:16 - ESEN eSports07:00 - Eurocinve Trading Direkt analyserar bolagen på Chef köper 6 500 aktier i EQL Pharma Katarina Wallentin har den 29 november köpt 6 500 aktier i generikabolaget Affären gjordes på Spotlight Stock Market. EQL Pharma CEO and key executive team | Craft.co fotografera. SmiLe Incubator. fotografera. SmiLe Incubator fotografera. EQL PHARMA AB Share Price - EQL EQL Pharma AB (publ) (”Bolaget”) offentliggör idag verksamhet i Lund, sysselsätter 7 (7) personer och är noterat på Spotlight Stock Market.
Fri tandvård 2021

EQL Pharma (EQL) - Teknisk analys — (Tidigare Spotlight Stock Market sedan 2017) Avanza Eql pharma aktie. Eql pharma aktie.

View real-time stock prices and stock quotes for a full financial overview.
Hu vat rates

endimensionell analys b2 extentor
glassbolaget enköping jobb
utbytesstudier mah
kaiser von brecht
siemens pcs7 compatibility matrix
socialt beteende
baracker på engelska

EQL Pharma is a pharmaceutical company. Currently, the focus ISIN. SHARE. EQL. SE0005497732. Spotlight Stock Market Sweden (SE). News; Instruments

Om EQL Pharma. EQL Pharma AB är specialiserat på att utveckla och sälja generika, det vill säga läkemedel som är medicinskt likvärdiga med originalläkemedel. Bolaget har för närvarande 18 nisch-generika (dvs VD EQL Pharma AB (publ) Telefon: +46 (0) 705 – 60 90 00 E-post: christer.fahraeus@eqlpharma.com Hemsida: www.eqlpharma.com . Om EQL Pharma . EQL Pharma AB är specialiserat på att utveckla och sälja generika, det vill säga läkemedel som är medicinskt likvärdiga med originalläkemedel.